<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
51662-1687-3
</NDCCode>
<PackageDescription>
30 POUCH in 1 CASE (51662-1687-3) / 1 BAG in 1 POUCH (51662-1687-2) / 250 mL in 1 BAG (51662-1687-1)
</PackageDescription>
<NDC11Code>
51662-1687-03
</NDC11Code>
<ProductNDC>
51662-1687
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Heparin Sodium
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Heparin Sodium
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20050630
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA018916
</ApplicationNumber>
<LabelerName>
HF Acquisition Co LLC, DBA HealthFirst
</LabelerName>
<SubstanceName>
HEPARIN SODIUM
</SubstanceName>
<StrengthNumber>
10000
</StrengthNumber>
<StrengthUnit>
[USP'U]/100mL
</StrengthUnit>
<Pharm_Classes>
Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-05-07
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20050630
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>